Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine
1996

EGFR Expression in Pancreatic Lesions Induced by Azaserine in Rats

Sample size: 35 publication Evidence: moderate

Author Information

Author(s): CJT Visser, RA de Weger, WTM van Blokland, I Seifert-Bock, MS Kobrin, M Korc, RA Woutersen

Primary Institution: TNO Nutrition and Food Research Institute

Hypothesis

The study investigates the expression of epidermal growth factor receptor (EGFR) in pancreatic lesions induced by azaserine in rats.

Conclusion

The study found that EGFR protein levels were decreased in preneoplastic lesions, while EGFR mRNA expression was higher in these lesions compared to normal cells.

Supporting Evidence

  • EGFR protein levels were decreased in preneoplastic lesions compared to normal pancreatic cells.
  • EGFR mRNA expression was positively correlated with the volume of atypical acinar cell nodules.
  • EGFR was not detected in advanced lesions such as acinar adenocarcinomas.

Takeaway

The study looked at how a protein called EGFR behaves in the pancreas of rats that were given a chemical to cause cancer. It found that in early lesions, the protein was lower, but the message to make it was higher.

Methodology

The study used Northern blotting, in situ hybridization, and immunohistochemistry to analyze EGFR expression in pancreatic tissues from rats treated with azaserine.

Limitations

RNA quality from small preneoplastic lesions was poor, limiting the analysis of EGFR expression in these specific lesions.

Participant Demographics

Albino Wistar WU rats were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication